SYDE1 and glioma: Considering that hsa-miR-520e is the target miRNA of SYDE1 with favorable outcomes in gliomas, the expression of the target lncRNAs (FGD5-AS1, MIR17HG, and SNHG16) of hsa-miR-520e was measured to calculate the prognostic ability of these signatures.